Anitha Jayaprakash, CEO and founder of Girihlet Inc., saw a big problem to be solved for millions of patients who were being prescribed drugs to treat painful symptoms and consequently suffered from drug interactions with debilitating side effects. In her own words, she shares her mission of building a company that would create the tools to monitor, diagnose and treat patients effectively.
Anitha says, “I want to be a part of the personalized medicine revolution, that recognizes each one of us has a unique set of needs. Girihlet’s Immune Scanner Technology Suite, for me, is a dream come true, a step forward to bringing safer and pain-free treatments to the millions who deserve it.”